Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial
暂无分享,去创建一个
R. Ferris | P. Moore | V. Ganju | A. Adjei | Y. Lou | N. Vogelzang | A. Prawira | O. Rahma | R. Hauke | R. Cohen | S. Antonia | S. Kaul | S. M. Goldberg | C. Aggarwal | A. Joshua | V. Atkinson | E. Bonvini | F. Arnaldez | A. Weickhardt | N. Lakhani | M. Seetharam | J. Baughman | A. R. Kalebasty | A. Birnbaum | A. Tolcher | Dan P Zandberg | Rosetta Cavallo | Linda Peng | Xiaoyu Zhang